Seaport Res Ptn Expects Reduced Earnings for Aspen Aerogels

Aspen Aerogels, Inc. (NYSE:ASPN - Free Report) - Equities researchers at Seaport Res Ptn reduced their FY2024 earnings estimates for shares of Aspen Aerogels in a research report issued on Monday, November 11th. Seaport Res Ptn analyst T. Curran now expects that the construction company will post earnings per share of $0.11 for the year, down from their previous estimate of $0.19. The consensus estimate for Aspen Aerogels' current full-year earnings is $0.11 per share. Seaport Res Ptn also issued estimates for Aspen Aerogels' Q4 2024 earnings at $0.09 EPS, Q1 2025 earnings at $0.06 EPS, Q2 2025 earnings at $0.16 EPS, Q3 2025 earnings at $0.19 EPS, Q4 2025 earnings at $0.19 EPS, FY2025 earnings at $0.60 EPS and FY2026 earnings at $0.83 EPS.

ASPN has been the subject of several other reports. Barclays reduced their price objective on Aspen Aerogels from $27.00 to $25.00 and set an "overweight" rating for the company in a report on Tuesday. Piper Sandler decreased their price target on shares of Aspen Aerogels from $36.00 to $33.00 and set an "overweight" rating on the stock in a research report on Tuesday, October 22nd. TD Cowen boosted their price objective on Aspen Aerogels from $36.00 to $41.00 and gave the company a "buy" rating in a research note on Tuesday, August 20th. StockNews.com upgraded Aspen Aerogels to a "sell" rating in a research note on Wednesday. Finally, HC Wainwright reissued a "buy" rating and issued a $30.00 target price on shares of Aspen Aerogels in a report on Wednesday, October 16th. One investment analyst has rated the stock with a sell rating, nine have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $28.70.

Aspen Aerogels Stock Down 0.1 %

Shares of NYSE ASPN traded down $0.02 on Thursday, reaching $15.52. 1,182,932 shares of the company's stock traded hands, compared to its average volume of 1,585,163. The company has a quick ratio of 2.82, a current ratio of 2.93 and a debt-to-equity ratio of 0.27. The company has a market cap of $1.27 billion, a price-to-earnings ratio of 1,553.55 and a beta of 2.21. The business's 50 day simple moving average is $22.44 and its two-hundred day simple moving average is $24.67. Aspen Aerogels has a 12 month low of $9.89 and a 12 month high of $33.15.

Hedge Funds Weigh In On Aspen Aerogels

Hedge funds have recently made changes to their positions in the stock. BNP Paribas Financial Markets boosted its stake in shares of Aspen Aerogels by 85.2% during the 1st quarter. BNP Paribas Financial Markets now owns 25,706 shares of the construction company's stock valued at $452,000 after buying an additional 11,823 shares during the last quarter. Oppenheimer & Co. Inc. acquired a new position in Aspen Aerogels in the first quarter worth about $388,000. Swiss National Bank raised its stake in Aspen Aerogels by 16.2% during the first quarter. Swiss National Bank now owns 120,500 shares of the construction company's stock valued at $2,121,000 after buying an additional 16,800 shares in the last quarter. Vanguard Group Inc. lifted its holdings in Aspen Aerogels by 5.1% during the 1st quarter. Vanguard Group Inc. now owns 3,619,702 shares of the construction company's stock worth $63,707,000 after buying an additional 175,906 shares during the last quarter. Finally, Healthcare of Ontario Pension Plan Trust Fund bought a new position in Aspen Aerogels during the first quarter worth $851,000. Institutional investors and hedge funds own 97.64% of the company's stock.

Insider Transactions at Aspen Aerogels

In other news, CEO Donald R. Young sold 63,355 shares of Aspen Aerogels stock in a transaction on Monday, September 30th. The shares were sold at an average price of $30.03, for a total transaction of $1,902,550.65. Following the completion of the sale, the chief executive officer now directly owns 483,640 shares of the company's stock, valued at approximately $14,523,709.20. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, CEO Donald R. Young sold 63,355 shares of Aspen Aerogels stock in a transaction dated Monday, September 30th. The shares were sold at an average price of $30.03, for a total value of $1,902,550.65. Following the sale, the chief executive officer now owns 483,640 shares of the company's stock, valued at $14,523,709.20. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Ricardo C. Rodriguez sold 32,465 shares of Aspen Aerogels stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $30.14, for a total value of $978,495.10. Following the completion of the sale, the chief financial officer now owns 20,790 shares in the company, valued at approximately $626,610.60. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 4.30% of the company's stock.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.